Clinical Site

Kansas City, Kansas 66160

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Cardiovascular Diseases, Elevated Lipoprotein(a), Hypertriglyceridemia, Parkinson Disease

Studies at this site

• Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease — Completed
• Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed